Rovin Capital UT ADV grew its stake in BlackRock, Inc. (NYSE:BLK – Free Report) by 22.7% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 292 shares of the asset manager’s stock after purchasing an additional 54 shares during the period. Rovin Capital UT ADV’s holdings in BlackRock were worth $299,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other institutional investors have also recently added to or reduced their stakes in the stock. Marino Stram & Associates LLC increased its stake in shares of BlackRock by 0.3% during the third quarter. Marino Stram & Associates LLC now owns 3,399 shares of the asset manager’s stock worth $3,227,000 after acquiring an additional 10 shares during the period. Fidelity D & D Bancorp Inc. boosted its holdings in BlackRock by 3.7% in the 3rd quarter. Fidelity D & D Bancorp Inc. now owns 277 shares of the asset manager’s stock valued at $263,000 after purchasing an additional 10 shares in the last quarter. Onyx Bridge Wealth Group LLC increased its position in BlackRock by 3.5% during the 3rd quarter. Onyx Bridge Wealth Group LLC now owns 328 shares of the asset manager’s stock worth $312,000 after purchasing an additional 11 shares during the period. Ballentine Partners LLC raised its stake in shares of BlackRock by 0.3% during the 3rd quarter. Ballentine Partners LLC now owns 3,424 shares of the asset manager’s stock worth $3,251,000 after buying an additional 11 shares in the last quarter. Finally, Harbor Capital Advisors Inc. lifted its holdings in shares of BlackRock by 0.4% in the 3rd quarter. Harbor Capital Advisors Inc. now owns 2,979 shares of the asset manager’s stock valued at $2,829,000 after buying an additional 11 shares during the period. Hedge funds and other institutional investors own 80.69% of the company’s stock.
Insider Activity
In other BlackRock news, Director Mark Wiedman sold 36,190 shares of the business’s stock in a transaction dated Friday, December 6th. The stock was sold at an average price of $1,045.90, for a total transaction of $37,851,121.00. Following the completion of the sale, the director now owns 6,480 shares of the company’s stock, valued at approximately $6,777,432. The trade was a 84.81 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, COO Robert L. Goldstein sold 54,000 shares of the firm’s stock in a transaction dated Thursday, December 5th. The stock was sold at an average price of $1,046.03, for a total value of $56,485,620.00. Following the completion of the transaction, the chief operating officer now owns 41,916 shares in the company, valued at approximately $43,845,393.48. This trade represents a 56.30 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 0.90% of the company’s stock.
BlackRock Price Performance
BlackRock (NYSE:BLK – Get Free Report) last posted its quarterly earnings data on Wednesday, January 15th. The asset manager reported $11.93 EPS for the quarter, beating analysts’ consensus estimates of $11.52 by $0.41. BlackRock had a return on equity of 15.52% and a net margin of 31.37%. The business had revenue of $5.68 billion for the quarter, compared to analyst estimates of $5.57 billion. During the same quarter last year, the company earned $9.66 earnings per share. The business’s revenue for the quarter was up 22.6% compared to the same quarter last year. On average, analysts forecast that BlackRock, Inc. will post 43.18 EPS for the current fiscal year.
BlackRock Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Monday, December 23rd. Shareholders of record on Thursday, December 5th were paid a dividend of $5.10 per share. This represents a $20.40 dividend on an annualized basis and a dividend yield of 2.01%. The ex-dividend date was Thursday, December 5th. BlackRock’s dividend payout ratio is presently 50.35%.
Analyst Ratings Changes
A number of research analysts recently weighed in on the company. Barclays dropped their price objective on BlackRock from $1,220.00 to $1,160.00 and set an “overweight” rating on the stock in a report on Monday. Wells Fargo & Company lowered their price target on shares of BlackRock from $1,200.00 to $1,155.00 and set an “overweight” rating on the stock in a research note on Tuesday, January 7th. Evercore ISI raised their price objective on shares of BlackRock from $1,040.00 to $1,160.00 and gave the company an “outperform” rating in a research note on Thursday, November 7th. Morgan Stanley upped their target price on shares of BlackRock from $1,245.00 to $1,261.00 and gave the stock an “overweight” rating in a research report on Friday, December 20th. Finally, The Goldman Sachs Group increased their target price on shares of BlackRock from $960.00 to $1,040.00 and gave the company a “buy” rating in a report on Thursday, October 3rd. Three research analysts have rated the stock with a hold rating and ten have issued a buy rating to the stock. According to data from MarketBeat, BlackRock presently has an average rating of “Moderate Buy” and a consensus price target of $1,100.50.
View Our Latest Analysis on BlackRock
About BlackRock
BlackRock, Inc is a publicly owned investment manager. The firm primarily provides its services to institutional, intermediary, and individual investors including corporate, public, union, and industry pension plans, insurance companies, third-party mutual funds, endowments, public institutions, governments, foundations, charities, sovereign wealth funds, corporations, official institutions, and banks.
Read More
- Five stocks we like better than BlackRock
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- 3 Defensive Stocks Analysts Are Bullish on to Kick Off the Year
- Stock Dividend Cuts Happen Are You Ready?
- Vistra Corp: Could 2025 Continue Its Streak of Outperformance?
- Basic Materials Stocks Investing
- Vertex’s Pain Drug: Big Pharma’s Next Major Success?
Want to see what other hedge funds are holding BLK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for BlackRock, Inc. (NYSE:BLK – Free Report).
Receive News & Ratings for BlackRock Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock and related companies with MarketBeat.com's FREE daily email newsletter.